Pulse Biosciences, Inc.

Equities

PLSE

US74587B1017

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 18:47:21 16/07/2024 BST			5-day change	1st Jan Change
18.82 ^USD	-3.51%		+28.29%	+54.49%

07-15	Pulse Biosciences Enters $60 Million Equity Distribution Agreement	MT
07-15	Pulse Biosciences, Inc. Provides Preliminary Earnings Guidance for the Three Months Ended June 30, 2024	CI

Pulse Biosciences, Inc. Provides Preliminary Earnings Guidance for the Three Months Ended June 30, 2024

July 15, 2024 at 12:10 pm

Pulse Biosciences, Inc. provided preliminary earnings Guidance for the three months ended June 30, 2024. For the period, the company expects GAAP net loss in the range of $10.7 million to $12.7 million.

Latest news about Pulse Biosciences, Inc.

Pulse Biosciences Enters $60 Million Equity Distribution Agreement	07-15	MT
Pulse Biosciences, Inc. Provides Preliminary Earnings Guidance for the Three Months Ended June 30, 2024	07-15	CI
Sector Update: Health Care Stocks Softer Late Afternoon	07-08	MT
Sector Update: Health Care Stocks Mixed in Afternoon Trading	07-08	MT
Top Midday Gainers	07-08	MT
Pulse Biosciences Shares Jump After FDA Breakthrough Device Designation for Cardiac Surgery System	07-08	MT
Pulse Biosciences Hit 2-Year High on FDA Status for Surgery System	07-08	DJ
Pulse Biosciences Receives US FDA Breakthrough Device Designation for nsPFA Cardiac Surgery System	07-08	MT
Pulse Biosciences Gets FDA's Breakthrough Status for Surgery System	07-08	DJ
Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation	07-08	CI
Pulse Biosciences, Inc.(NasdaqCM:PLSE) dropped from Russell Microcap Value Index	06-30	CI
Pulse Biosciences, Inc.(NasdaqCM:PLSE) dropped from Russell 2000 Value Index	06-30	CI
Pulse Biosciences, Inc.(NasdaqCM:PLSE) dropped from Russell 3000 Value Index	06-30	CI
Pulse Biosciences, Inc.(NasdaqCM:PLSE) dropped from Russell 2500 Value Index	06-30	CI
Pulse Biosciences, Inc.(NasdaqCM:PLSE) dropped from Russell Small Cap Comp Value Index	06-30	CI
Pulse Biosciences, Inc.(NasdaqCM:PLSE) dropped from Russell 3000E Value Index	06-30	CI
Pulse Biosciences's Preliminary Results of Rights Offering Sets Final Subscription Price at $10 per Unit	06-28	MT
Shelley D. Spray Does Not Stand for Reelection from the Board of Pulse Biosciences, Inc	06-07	CI
Pulse Biosciences Moves New Record Date for Rights Offering	05-20	MT
Pulse Biosciences Appoints Burke Barrett as President, CEO	05-14	MT
Pulse Biosciences, Inc Announces CEO Changes	05-14	CI
Pulse Biosciences, Inc Announces Executive Changes	05-14	CI
Pulse Biosciences, Inc. Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System	05-09	CI
Transcript : Pulse Biosciences, Inc., Q1 2024 Earnings Call, May 07, 2024	05-07
Pulse Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI

Chart Pulse Biosciences, Inc.

Duration

Period

More charts

Company Profile

Pulse Biosciences, Inc. is a bioelectric medicine company. The Companyâs proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Companyâs Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.

Sector

Advanced Medical Equipment & Technology

Calendar

07/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
PULSE BIOSCIENCES, INC.	+54.49%	1.19B
THERMO FISHER SCIENTIFIC	+4.12%	208B
DANAHER CORPORATION	+8.17%	182B
INTUITIVE SURGICAL, INC.	+28.93%	155B
BOSTON SCIENTIFIC CORPORATION	+34.83%	115B
SIEMENS HEALTHINEERS AG	+2.55%	66.52B
EDWARDS LIFESCIENCES CORPORATION	+14.69%	53.93B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.47%	46.26B
AGILENT TECHNOLOGIES, INC.	-3.07%	38.22B
GE HEALTHCARE TECHNOLOGIES INC.	+6.12%	36.6B

Other Advanced Medical Equipment & Technology